GlassScriptPhysician profile
Syed Z Ullah
NPI 1033498118
$3,536.19
in general payments reported to CMS, 2019-2025
32 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $200 · 2021: $637 · 2022: $627 · 2023: $413 · 2024: $649 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $633.10 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $424.92 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Lilly USA, LLC | $324.99 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $294.13 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $257.74 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $205.06 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Regeneron Healthcare Solutions, INC. | $198.36 | 2019 | |
| Shield Therapeutics INC | $194.58 | 2023-2025 | Accrufer |
| Amarin Pharma, INC. | $143.76 | 2019-2021 | |
| Novo Nordisk INC | $137.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $86.52 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $56.88 | 2023-2025 | |
| Astellas Pharma US INC | $49.96 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $41.00 | 2019-2025 | Capvaxive, Gardasil 9 |
| Kowa Pharmaceuticals America, INC. | $38.68 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $37.17 | 2024 | Voquezna |
| Asahi Intecc USA, INC. | $36.45 | 2025 | Asahi Coronary Wires |
| Nabriva Therapeutics, Plc | $36.41 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.30 | 2023-2024 | Xifaxan, Trulance |
| Teva Pharmaceuticals USA, INC. | $34.69 | 2019-2022 | |
| Ultragenyx Pharmaceutical INC. | $31.11 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $28.93 | 2021 | |
| Pfizer INC. | $28.27 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $27.05 | 2021 | |
| Linus Health, INC. | $24.33 | 2022 | |
| Arbor Pharmaceuticals, INC. | $23.07 | 2020 | |
| Electromed, INC. | $20.27 | 2021 | |
| Gilead Sciences, INC. | $18.85 | 2021 | |
| Sumitomo Pharma America, INC. | $18.67 | 2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $17.71 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.43 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.24 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.